Johann ACBR, Caldeira PC, Caliari MV, Gomez RS, Aguiar MCF, Mesquita RA. Metallothionein immunoexpression in non-syndromic and syndromic keratocystic odontogenic tumour. Med Oral Patol Oral Cir Bucal. 2015 Jul 1;20 (4):e408-12.  

 

 

doi:10.4317/medoral.20418

http://dx.doi.org/doi:10.4317/medoral.20418

 

 

1. Gorlin RJ. Nevoid basal-cell carcinoma syndrome. Medicine (Baltimore). 1987;66:98-113.
http://dx.doi.org/10.1097/00005792-198703000-00002

 

2. Lo Muzio L, Staibano S, Pannone G, Bucci P, Nocini PF, Bucci E, et al. Expression of cell cycle and apoptosis-related proteins in sporadic odontogenic keratocysts and odontogenic keratocysts associated with the nevoid basal cell carcinoma syndrome. J Dent Res. 1999;78:1345-53.
http://dx.doi.org/10.1177/00220345990780070901

 

3. Kimi K, Kumamoto H, Ooya K, Motegi K. Immunohistochemical analysis of cell-cycle- and apoptosis-related factors in lining epithelium of odontogenic keratocysts. J Oral Pathol Med. 2001;30:434-42.
http://dx.doi.org/10.1034/j.1600-0714.2001.300709.x

 

4. Ohki K, Kumamoto H, Ichinohasama R, Sato T, Takahashi N, Ooya K. PTC gene mutations and expression of SHH, PTC, SMO, and GLI-1 in odontogenic keratocysts. Int J Oral Maxillofac Surg. 2004;33:584-92.
http://dx.doi.org/10.1016/j.ijom.2004.01.013

 

5. Kolr Z, Geierov M, Bouchal J, Pazdera J, Zboril V, Tvrdý P. Immunohistochemical analysis of the biological potential of odontogenic keratocysts. J Oral Pathol Med. 2006;35:75-80.
http://dx.doi.org/10.1111/j.1600-0714.2006.00382.x

 

6. Katase N, Nagatsuka H, Tsujigiwa H, Gunduz M, Tamamura R, Pwint Hp, et al. Analysis of the neoplastic nature and biological potential of sporadic and nevoid basal cell carcinoma syndrome-associated keratocystic odontogenic tumor. J Oral Pathol Med. 2007;36:550-4.
http://dx.doi.org/10.1111/j.1600-0714.2007.00578.x

 

7. Gonzlez Moles MA, Mosqueda-Taylor A, Esteban F, Gil-Montoya JA, Daz-Franco MA, Delgado M, et al. Cell proliferation associated with actions of the substance P/NK-1 receptor complex in keratocystic odontogenic tumours. Oral Oncol. 2008;44:1127-33.
http://dx.doi.org/10.1016/j.oraloncology.2008.02.010

 

8. Woolgar JA, Rippin JW, Browne RM. A comparative study of the clinical and histological features of recurrent and non-recurrent odontogenic keratocysts. J Oral Pathol. 1987;16:124-8.
http://dx.doi.org/10.1111/j.1600-0714.1987.tb01478.x

 

9. Dominguez FV, Keszler A. Comparative study of keratocysts, associated and non-associated with nevoid basal cell carcinoma syndrome. J Oral Pathol. 1988;17:39-42.
http://dx.doi.org/10.1111/j.1600-0714.1988.tb01503.x

 

10. Brannon RB. The odontogenic keratocyst. A clinicopathologic study of 312 cases. Part II. Histologic features. Oral Surg Oral Med Oral Pathol. 1977;43:233-55.
http://dx.doi.org/10.1016/0030-4220(77)90161-X

 

11. Hecht D, Jung D, Prabhu VV, Munson PJ, Hoffman MP, Kleinman HK. Metallothionein promotes laminin-1-induced acinar differentiation in vitro and reduces tumor growth in vivo. Cancer Res. 2002;62:5370-4.

 

12. Sundelin K, Jadner M, Norberg-Spaak L, Davidsson A, Hellquist HB Metallothionein and Fas (CD95) are expressed in squamous cell carcinoma of the tongue. Eur J Cancer. 1997;33:1860-4.
http://dx.doi.org/10.1016/S0959-8049(97)00216-5

 

13. Formigari A, Irato P, Santon A. Zinc, antioxidant systems and metallothionein in metal mediated-apoptosis: biochemical and cytochemical aspects. Comp Biochem Physiol C Toxicol Pharmacol. 2007;146:443-59.
http://dx.doi.org/10.1016/j.cbpc.2007.07.010

 

14. Pedersen M, Larsen A, Stoltenberg M, Penkowa M. The role of metallothionein in oncogenesis and cancer prognosis. Prog Histochem Cytochem. 2009;44:29-64.
http://dx.doi.org/10.1016/j.proghi.2008.10.001

 

15. Vask M. Advances in metallothionein structure and functions. J Trace Elem Med Biol. 2005;19:13-7.
http://dx.doi.org/10.1016/j.jtemb.2005.03.003

 

16. Mateus GC, Lanza GH, De Moura PH, Marigo HA, Horta MC. Cell proliferation and apoptosis in keratocystic odontogenic tumors. Med Oral Patol Oral Cir Bucal. 2008; 13:E697-702.

 

17. Gurgel CA, Ramos EA, Azevedo RA, Sarmento VA, Silva Carvalho AM, Santos JN. Expression of Ki-67, p53 and p63 proteins in keratocyst odontogenic tumours: an immunohistochemical study. J Mol Histol. 2008;39:311-6.
http://dx.doi.org/10.1007/s10735-008-9167-0

 

18. Ba K, LI X, Wang H, Liu Y, Zheng G, Yang Z, et al. Correlation between imaging features and epithelial cell proliferation in keratocystic odontogenic tumour. Dentomaxillofac Radiol. 2010;39:368-74.
http://dx.doi.org/10.1259/dmfr/27538271

 

19. Pan S, Li TJ. PTCH1 mutations in odontogenic keratocysts: are they related to epithelial cell proliferation? Oral Oncol. 2009;45:861-5.
http://dx.doi.org/10.1016/j.oraloncology.2009.02.003

 

20. Johann AC, Caldeira PC, Caliari MV, De Abreu MH, Aguiar MC, Mesquita RA. Metallothionein in the radicular, dentigerous, orthokeratinized odontogenic cysts and in keratocystic odontogenic tumor. Journal of Oral Pathology & Medicine. 2011;40:270-6.
http://dx.doi.org/10.1111/j.1600-0714.2010.00971.x

 

21. Hirshberg A, Lib M, Kozlovsky A, Kaplan I. The influence of inflammation on the polarization colors of collagen fibers in the wall of odontogenic keratocyst. Oral Oncol. 2007;43:278-82.
http://dx.doi.org/10.1016/j.oraloncology.2006.03.019

 

22. Cardoso SV, Barbosa HM, Candellori IM, Loyola AM, Aguiar MC. Prognostic impact of metallothionein on oral squamous cell carcinoma. Virchows Arch. 2002;441:174-8.
http://dx.doi.org/10.1007/s00428-001-0588-3

 

23. Brazo-Silva MT, Cardoso SV, De Faria PR, Dias FL, Lima RA, Eisenberg AL, et al. Adenoid cystic carcinoma of the salivary gland: a clinicopathological study of 49 cases and of metallothionein expression with regard to tumour behaviour. Histopathology. 2013;63:802-9.
http://dx.doi.org/10.1111/his.12227

 

24. Gumulec J, Raudenska M, Adam V, Kizek R, Masarik M. Metallothionein - immunohistochemical cancer biomarker: a meta-analysis. PLoS One. 2014;9:e85346.
http://dx.doi.org/10.1371/journal.pone.0085346

 

25. Nishimura H, Nishimura N, Tohyama C. Immunohistochemical localization of metallothionein in developing rat tissues. J Histochem Cytochem. 1989;37:715-22.
http://dx.doi.org/10.1177/37.5.2703706

 

26. Cherian MG, Jayasurya A, Bay BH. Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat Res. 2003;533:201-9.
http://dx.doi.org/10.1016/j.mrfmmm.2003.07.013

 

27. Johann AC, Caldeira PC, Souto GR, Abreu MHNG, Aguiar MCF, Mesquita RA. Metallothionein immunoexpression in selected benign epithelial odontogenic tumors. J Oral Pathol Med. 2014;43:177-82.
http://dx.doi.org/10.1111/jop.12122

 

28. Ioachim EE, Kitsiou E, Carassavoglou C, Stefanaki S, Agnantis NJ. Immunohistochemical localization of metallothionein in endometrial lesions. J Pathol. 2000;191:269-73.
http://dx.doi.org/10.1002/1096-9896(2000)9999:9999<::AID-PATH616>3.0.CO;2-Q

 

29. Szelachowska J, Dziegiel P, Jelen-Krzeszewska J, Jelen M, Tarkowski R, Wlodarska I, et al. Prognostic significance of nuclear and cytoplasmic expression of metallothioneins as related to proliferative activity in squamous cell carcinomas of oral cavity. Histol Histopathol. 2008;23:843-51.

 

30. Kaplan I, Hirshberg A. The correlation between epithelial cell proliferation and inflammation in odontogenic keratocyst. Oral Oncol. 2004;40:985-91.
http://dx.doi.org/10.1016/j.oraloncology.2004.04.017